Clinical Trial Update: Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab

View source ↗

Summary

This clinical trial case review summarizes outcomes of patients with betel nut-induced oral squamous cell carcinoma treated with pembrolizumab and cetuximab. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Commonwealth Healthcare Corporation | Conditions: Oral Squamous Cell Carcinoma (OSCC) | Status: COMPLETED